Showing results (51-60 of 121) with videos related to
Sort By:
Pageof 13
International Journal of Laboratory Hematology|February 7, 2018
State of the art vs biological variability: Comparison on hematology parameters using Spanish EQAS dataA Molina, L Guiñon, A Perez, et al.Leukemia|June 1, 1992
Recombinant alpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemiaN Villamor, J C Reverter, E Montserrat, et al.Thrombosis Research|December 22, 1999
Assessment of potential thrombogenicity of coagulation factor IX concentrates in an in vitro model of human thrombogenesisA M Galan, J C Reverter, J Bozzo, et al.Human Reproduction (Oxford, England)|May 1, 1997
First-trimester repeated abortion is not associated with activated protein C resistanceJ Balasch, J C Reverter, F Fábregues, et al.Platelets|November 4, 2010
Absence of Effect of DDAVP Infusion on Platelet Glycoprotein Ib/IX and IIb/IIIa Complexes, and their Interaction with Newly Released von Willebrand FactorJ Rivera, M J Roig, J Monteagudo, et al.Thrombosis and Haemostasis|November 1, 1991
Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromeJ Monteagudo, A Pereira, J C Reverter, et al.Gut|June 22, 2000
Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanismA Salas, M Sans, A Soriano, et al.International Journal of Dermatology|June 1, 1996
Utility of bone marrow and liver biopsies for staging cutaneous T-cell lymphomaR M Martí, T Estrach, J C Reverter, et al.British Journal of Rheumatology|January 1, 1997
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndromeM Teixidó, J Font, J C Reverter, et al.Alimentary Pharmacology & Therapeutics|April 16, 2003
The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's diseaseM Sans, D Tàssies, M Pellisé, et al.Pageof 13